Martin Brecher

Head of Clinical Development at NeuroRx, Inc.

Martin Brecher

Martin Brecher

Head of Clinical Development at NeuroRx, Inc.

Biography

Martin Brecher is on the board of Immunetrics, Inc. In his past career Dr. Brecher occupied the position of Director-Medical Sciences at AstraZeneca Plc and Faculty Member at State University of New York at Downstate Medical Center. He received an undergraduate degree from Massachusetts Institute of Technology, a doctorate from The State University of New York and an MBA from the University of Pennsylvania.

Overview
RelSci Relationships

961

Number of Boards

1

Relationships
RelSci Relationships are individuals Martin Brecher likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder, Chairman, President & Chief Executive Officer at LaunchCyte LLC

Relationship likelihood: Strong

Chief Executive Officer at Immunetrics, Inc.

Relationship likelihood: Strong

Founder & Chief Executive Officer at NeuroRx, Inc.

Relationship likelihood: Strong

Co-Founder at NeuroRx, Inc.

Relationship likelihood: Strong

Chief Commercial Officer at NeuroRx, Inc.

Relationship likelihood: Strong

Former Chief Scientific Officer at NeuroRx, Inc.

Relationship likelihood: Strong

Chief Legal Officer at NeuroRx, Inc.

Relationship likelihood: Strong

Chief Medical Officer at Mesoblast Ltd.

Relationship likelihood: Strong

Executive Director, Corporate Controller & Principal Accounting Officer at Immunomedics Inc.

Relationship likelihood: Strong

Vice President & General Manager, Early Clinical Development at Covance, Inc.

Relationship likelihood: Average

Paths to Martin Brecher
Potential Connections via
Relationship Science
You
Martin Brecher
Head of Clinical Development at NeuroRx, Inc.
Education

Massachusetts Institute of Technology (MIT) is a private research university located in Cambridge, Massachusetts, United States. MIT has five schools and one college, containing a total of 32 academic departments, with a strong emphasis on scientific, engineering, and technological education and research. Founded in 1861 in response to the increasing industrialization of the United States, the institute used a polytechnic university model and stressed laboratory instruction. MIT was elected to the Association of American Universities in 1934.

The State University of New York is the largest comprehensive university system in the United States, educating approximately 468,000 students in more than 7,500 degree and certificate programs, and more than 1.8 million NYS citizens in professional development and personal enrichment programs, on 64 college and university campuses. There are nearly 3 million SUNY alumni worldwide.

The University of Pennsylvania (commonly referred to as Penn or UPenn) is a private, Ivy League university, located in Philadelphia, Pennsylvania, United States. Penn considers itself the fourth-oldest institution of higher education in the United States, as well as the first university in the United States with both undergraduate and graduate studies.

Career History
Head of Clinical Development
Current

NeuroRx, Inc. is a clinical stage, small molecule pharmaceutical company developing novel therapeutics for the treatment of central nervous system disorders. The company is built upon 30 years of basic science and clinical expertise in understanding the role of the brain’s N-methyl-D-aspartate (NMDA) receptor in regulating human thought processes in general and in regulating depression and suicidality in specific. The company’s lead drug treatment regimen is NRX-100/NRX-101, the first sequential drug treatment regimen for Bipolar Depression in patients with Acute Suicidal Ideation & Behavior (ASIB).

Director-Medical Sciences
Prior

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Faculty Member
Prior

Formally known as The State University of New York Health Science Center at Brooklynbut better known to our patients and Brooklyn neighbors as SUNY Downstate Medical Centerthey are older than the Brooklyn Bridge. They trace their roots back to 1860, when a school of medicine was founded at the Long Island College Hospital. The new college's faculty revolutionized medical education in this country by bringing the teaching of medicine to the hospital bedside, thus rejecting the idea that physicians should be trained exclusively in university lecture halls. Today, SUNY Downstate is one of the nation's leading urban medical centers. SUNY Downstate comprises a College of Medicine, College of Health Related Professions, College of Nursing, School of Graduate Studies, School of Public Health, and University Hospital of Brooklyn. The quality of our education, research, and patient care programs was confirmed with the awarding of the Nobel Prize in Medicine to Dr. Robert Furchgott, a member of our School of Graduate Studies faculty since 1956. Dr. Furchgott's identification of nitric oxide as a signalling molecule important in vascular health has revolutionized care for heart, stroke, impotence, and other diseases. As the only academic medical center in Brooklyn, they serve a large populationover 2.3 million peopleand one that is among the most diverse in the world. They are also an engine of opportunity for students interested in pursuing careers in health care. Many of their students are the first in their families to attend college.

Boards & Committees
Director
Current

Immunetrics, Inc. operates as a bio-simulation company. The company was founded by Carson Chow, Timothy R. Billiar, Gilles Clermont, Mitchell P. Fink and Yoram Vodovotz in 2001 and is headquartered in Pittsburgh, PA.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Martin Brecher. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Martin Brecher's profile does not indicate a business or promotional relationship of any kind between RelSci and Martin Brecher.